Literature DB >> 1352234

[Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].

K Joseph1, J Stapp, J Reinecke, H Höffken, R Benning, C Neuhaus, M E Trautmann, W B Schwerk, R Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1352234     DOI： 10.1055/s-2008-1062406

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  10 in total

1.  [Clinical value of somatostatin receptor scintigraphy. Studies of pre- and intraoperative localization of gastrointestinal and pancreatic tumors].

Authors:  S Adams; R P Baum; M Adams; H J Wenisch; P M Schumm-Draeger; A Encke; K H Usadel; G Hör
Journal:  Med Klin (Munich)       Date:  1997-03-15

2.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 3.  The diagnostic utility of somatostatin receptor scintigraphy in oncology.

Authors:  R Valkema; J Steens; F J Cleton; E K Pauwels
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Authors:  R Arnold; M E Trautmann; W Creutzfeldt; R Benning; M Benning; C Neuhaus; R Jürgensen; K Stein; H Schäfer; C Bruns; H J Dennler
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

5.  Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.

Authors:  Dimitris Dimitroulopoulos; Dimitris Xynopoulos; Klisthenis Tsamakidis; Emmanouel Paraskevas; Athanassios Zisimopoulos; Efthymios Andriotis; Ekaterini Fotopoulou; Marios Kontis; Ioannis Paraskevas
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

6.  Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.

Authors:  T Zimmer; U Stölzel; M Bäder; K Koppenhagen; B Hamm; H Buhr; E O Riecken; B Wiedenmann
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 7.  [PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Authors:  K Scheidhauer; M Miederer; F C Gaertner
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

Review 8.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

9.  High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.

Authors:  G Hildebrandt; K Scheidhauer; C Luyken; H Schicha; N Klug; P Dahms; B Krisch
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.

Authors:  W A Breeman; L J Hofland; M van der Pluijm; P M van Koetsveld; M de Jong; B Setyono-Han; W H Bakker; D J Kwekkeboom; T J Visser; S W Lamberts
Journal:  Eur J Nucl Med       Date:  1994-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.